Kronox Lab Sciences Ltd Cash Flow Conversion Efficiency
Kronox Lab Sciences Ltd cash flow conversion efficiency. Based on the latest financial reports, Kronox Lab Sciences Ltd (KRONOX) has a cash flow conversion efficiency ratio of 0.104x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs104.97 Million ≈ $1.14 Million USD) by net assets (Rs1.01 Billion ≈ $10.97 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Kronox Lab Sciences Ltd (2022–2026)
Cash flow conversion efficiency of Kronox Lab Sciences Ltd from 2022 to 2026. This chart illustrates how Kronox Lab Sciences Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View today's stock price for Kronox Lab Sciences Ltd for real-time trading data and today's change.
Kronox Lab Sciences Ltd Cash Flow Conversion Ratio Explained
Kronox Lab Sciences Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Kronox Lab Sciences Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Kronox Lab Sciences Ltd ranked by their cash flow conversion efficiency. Also see KRONOX company net worth for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
VIVANI MED.INC. NEW O.N.
F:U5P
|
-0.427x |
|
Vera Bradley Inc
NASDAQ:VRA
|
-0.042x |
|
North Media A/S
CO:NORTHM
|
0.010x |
|
Kwong Fong Industries Corp
TW:1416
|
0.017x |
|
Xavis Co. Ltd
KQ:254120
|
0.045x |
|
Strix Group Plc
F:SG9
|
N/A |
|
Cellectis SA
NASDAQ:CLLS
|
-0.348x |
|
Investec plc
LSE:INVR
|
0.009x |
Annual Cash Flow Conversion Efficiency for Kronox Lab Sciences Ltd (2022–2026)
The table below shows the annual cash flow conversion efficiency of Kronox Lab Sciences Ltd from 2022 to 2026. Review cash generation quality of Kronox Lab Sciences Ltd to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2026-03-31 | Rs1.16 Billion ≈ $12.56 Million |
Rs238.93 Million ≈ $2.58 Million |
0.206x | -39.61% |
| 2025-03-31 | Rs901.05 Million ≈ $9.74 Million |
Rs306.97 Million ≈ $3.32 Million |
0.341x | +29.71% |
| 2024-03-31 | Rs663.05 Million ≈ $7.17 Million |
Rs174.15 Million ≈ $1.88 Million |
0.263x | -40.33% |
| 2023-03-31 | Rs446.79 Million ≈ $4.83 Million |
Rs196.65 Million ≈ $2.13 Million |
0.440x | +96.91% |
| 2022-03-31 | Rs403.53 Million ≈ $4.36 Million |
Rs90.20 Million ≈ $975.48K |
0.224x | -- |
About Kronox Lab Sciences Ltd
Kronox Lab Sciences Limited manufactures and sells fine chemicals, inorganic chemicals, phosphates, and metallic chemicals in India and internationally. The company provides bulk reagents comprising ACS reagents, as well as LR, AR, and GR reagents; bulk ingredients that includes oral care, pharmacopoeia, food and nutraceutical, personal care and cosmetics, and veterinary pharma and animal health;… Read more